🔍 Hiring Alert: We’re seeking bioinformaticians at various levels to elevate our translational research at Elshad Hasanov, MD, PhD Pelotonia Institute for Immuno-Oncology Join us in navigating the complexities of data to unveil groundbreaking findings 🧬🖥️ Your RTs to spread the word are greatly appreciated 🙏

All that is small is not a small cell carcinoma: Thoracic SMARCA4 undifferentiated tumors masquerading as SCLC. bit.ly/3UPnMBk

🚨JOB ALERT🚨 #PIIO #ImmuneMonitoring & Discovery Platform (go.osu.edu/imdp) seeks a #FlowCytometry Scientist w/ at least 5-10 yrs experience w/ flow instruments (Cytek Aurora, BD FACS Melody, etc.) & proficiency in FlowJo & Omiq. For more info👇 go.osu.edu/imdpflow

⭐️Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies AACR Clinical Cancer Research Cancer Research Communications aacrjournals.org/cancerrescommu…

Commentary by Manz and Barnett discusses the role of “linchpin” oncologists, central to patients in cancer care referral networks such as rural and low SES communities. Read more here: oxford.ly/44J8a5L Michael L. Barnett Dana-Farber Harvard Medical School Harvard T.H. Chan School of Public Health

The rate of new HR-/HER2- (or “triple-negative”) #BreastCancer cases is higher than average for Non-Hispanic Black women. The average rate of new cases increased across all racial and ethnic groups from 2016 to 2021. SEER*Explorer has more stats: buff.ly/3k5fouk #BCSM

.Johns Hopkins University invites applications and nominations for the position of Editor-in-Chief (EiC) of a new open access (OA), online-only, peer-reviewed epidemiology journal, AJE Open, part of the American Journal of Epidemiology. tinyurl.com/4dv66f4u

A7: @NCIEpiTraining explains that disaggregated data can reveal variations in health disparities experienced by #AAs & #NHPIs and can help avoid making misleading conclusions about AA and NHPI health: dceg.cancer.gov/news-events/ne… #SourceForBetterHealth (1/2)

Female breast cancer incidence rate. Ohio ranked #9 in the nation

Kudos to #PIIO, Ohio State Medical Oncology faculty recruit Dr. Tim Gauntner, who rec'd a 2024 Conquer Cancer, the ASCO Foundation Young Investigator Award. W/ interests in #genitourinary #oncology, he works in the areas of #immune regulation in the #TME, steroid hormone signaling, & hormonal carcinogenesis.

Read the article by the recipients of the Cancer Prevention Research Award for Outstanding Journal Article, Denise Cecil et al.— COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors & Increase the Influx of Type I Tumor-infiltrating Lymphocytes. doi.org/10.1158/1940-6…

Join our Ohio State Medical Oncology faculty at #ASCO24 to learn about our latest research! Ashish Manne Shafia Rahman Daniel Stover, MD, FASCO Carolyn Presley, MD MHS

Close out Asian American, Native Hawaiian, and Pacific Islander Heritage Month by listening to our new #SpeakingofScience episode! We break down some of the history that has shaped #AANHPI experiences and perspectives and explain why researchers like Dr. Jacqueline Vo are working

Excited to hear Dr. Ephraim Ansa-Addo's presentation on modulating #TregCells for #cancer #immunotherapy during our #PIIO Research-in-Progress! His research focuses on defining the functions of various subsets of #TregCells in the #TME & how they affect cancer progression.

RxPONDER: outcomes by race+ ethnicity (n=3102), median f/u 8 yrs (5% NH Black, 70% NH White) Worse outcome for NH Blacks c/w NH whites NH Blacks have higher mean proliferation axis score c/w NH Whites , but BMI may also have a role OncoAlert #ASCO24 #bcsm

Carolina Breast Cancer Study: assoc between MHC I +II and race. (total n=1630, 787=black; 68% HR+/HER2-) presented by Sonya Reid MHCI + II more common in black in HR+/HER2- BC (this could potentially translate into improved response to IO) OncoAlert #bcsm #ASCO24

Most viewed in the last 7 days from JAMA Oncology: Is there an association between body composition metrics automatically extracted from imaging and prognoses in patients with advanced NSCLC receiving systemic therapy? ja.ma/3Vh5iKl

Tricking the animal model that it is getting excess nutrients leads to inflammation, organ damage, and shortened lifespan, reversed by anti-inflammatory Rx nature.com/articles/s4358… Nature Aging Ana Ortega Molina Efeyan Lab CNIO Stop Cancer Agencia Estatal de Investigación Instituto de Salud Carlos III (ISCIII) @justsaysinmice

September 16-20 is National Postdoc appreciation week. #NPAW2024 buff.ly/4d7GFFu

En Cheng visited OSU and presented his research on body composition. Fascinating presentation and discussion! En Cheng The James at Ohio State